NO740327L - Analogous process for the preparation of pharmacologically active imidazopyridines. - Google Patents

Analogous process for the preparation of pharmacologically active imidazopyridines.

Info

Publication number
NO740327L
NO740327L NO740327A NO740327A NO740327L NO 740327 L NO740327 L NO 740327L NO 740327 A NO740327 A NO 740327A NO 740327 A NO740327 A NO 740327A NO 740327 L NO740327 L NO 740327L
Authority
NO
Norway
Prior art keywords
preparation
pharmacologically active
analogous process
imidazopyridines
active imidazopyridines
Prior art date
Application number
NO740327A
Other languages
Norwegian (no)
Other versions
NO139386B (en
NO139386C (en
Inventor
Eberhard Kutter
Volkard Austel
Willi Diederen
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2305339A external-priority patent/DE2305339C3/en
Priority claimed from DE2361757A external-priority patent/DE2361757A1/en
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO740327L publication Critical patent/NO740327L/en
Publication of NO139386B publication Critical patent/NO139386B/en
Publication of NO139386C publication Critical patent/NO139386C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194Radicals derived from thio- or thiono carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO740327A 1973-02-03 1974-02-01 ANALOGICAL PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE IMIDAZOPYRIDINES NO139386C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2305339A DE2305339C3 (en) 1973-02-03 1973-02-03 Imidazo [4,5-b] pyridines, their preparation and their use as cardiotonica
DE2361757A DE2361757A1 (en) 1973-12-12 1973-12-12 Cardioactive imidazopyridines - substd. 2-phenyl 1H(or3H) imidazo (4,5,6) pyridines with positive inotropic and platelet aggregation inhibiting activity

Publications (3)

Publication Number Publication Date
NO740327L true NO740327L (en) 1974-08-06
NO139386B NO139386B (en) 1978-11-20
NO139386C NO139386C (en) 1979-02-28

Family

ID=25764640

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740327A NO139386C (en) 1973-02-03 1974-02-01 ANALOGICAL PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE IMIDAZOPYRIDINES

Country Status (24)

Country Link
JP (1) JPS5748556B2 (en)
AT (1) AT332873B (en)
BG (1) BG23902A3 (en)
CA (1) CA1041502A (en)
CH (1) CH605939A5 (en)
CS (1) CS200169B2 (en)
DD (1) DD108989A5 (en)
DK (1) DK140760B (en)
ES (1) ES422450A1 (en)
FI (1) FI58126C (en)
FR (1) FR2215968B1 (en)
GB (1) GB1445824A (en)
HK (1) HK4080A (en)
HU (1) HU170909B (en)
IE (1) IE39066B1 (en)
IL (1) IL44127A (en)
NL (1) NL173645C (en)
NO (1) NO139386C (en)
PH (1) PH14988A (en)
PL (1) PL93127B1 (en)
RO (2) RO79057A (en)
SE (1) SE411451B (en)
SU (2) SU563917A3 (en)
YU (2) YU36955B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49109394A (en) * 1973-02-27 1974-10-17
DE3132754A1 (en) * 1981-08-19 1983-03-03 Merck Patent Gmbh, 6100 Darmstadt 2-Arylimidazo[4,5-b]pyridines, pharmaceutical preparations containing these compounds, and processes for their preparation
ES517193A0 (en) * 1981-11-10 1983-12-01 Wellcome Found A PROCEDURE FOR THE PREPARATION OF NEW IMIDAZO DERIVATIVES (4,5-C) PIRIDINA.
ZA832938B (en) * 1982-05-03 1984-12-24 Lilly Co Eli 2-phenylimidazo(4,5-c)pyridines
US4772600A (en) * 1986-06-09 1988-09-20 A. H. Robins Company, Inc. Fused imidazoheterocyclic compounds and pharmaceutical compositions
JPH01190663A (en) * 1988-01-22 1989-07-31 Terumo Corp Cysteamine derivative and antirheumatic agent containing said derivative
US6653309B1 (en) 1999-04-26 2003-11-25 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme technical field of the invention
US9273027B2 (en) 2010-02-24 2016-03-01 Research Triangle Institute Arylpiperazine opioid receptor antagonists
CN103261170B (en) * 2010-12-24 2016-08-24 住友化学株式会社 Fused heterocyclic compound and the purposes for Pest control thereof
WO2013191189A1 (en) * 2012-06-21 2013-12-27 住友化学株式会社 Fused heterocyclic compound
JPWO2013191188A1 (en) 2012-06-22 2016-05-26 住友化学株式会社 Fused heterocyclic compounds

Also Published As

Publication number Publication date
BG23902A3 (en) 1977-11-10
SE411451B (en) 1979-12-27
YU36955B (en) 1984-08-31
JPS49102693A (en) 1974-09-27
NO139386B (en) 1978-11-20
DK140760B (en) 1979-11-12
CH605939A5 (en) 1978-10-13
YU110480A (en) 1982-06-18
IE39066B1 (en) 1978-08-02
GB1445824A (en) 1976-08-11
SU563917A3 (en) 1977-06-30
RO84276A (en) 1984-05-23
HU170909B (en) 1977-09-28
ATA16474A (en) 1976-02-15
JPS5748556B2 (en) 1982-10-16
HK4080A (en) 1980-02-08
IL44127A (en) 1977-05-31
PH14988A (en) 1982-03-12
DK140760C (en) 1980-04-21
AT332873B (en) 1976-10-25
NL7401254A (en) 1974-08-06
ES422450A1 (en) 1976-05-01
SU634673A3 (en) 1978-11-25
PL93127B1 (en) 1977-05-30
FI58126B (en) 1980-08-29
NO139386C (en) 1979-02-28
FR2215968B1 (en) 1977-01-28
DD108989A5 (en) 1974-10-12
IL44127A0 (en) 1974-05-16
IE39066L (en) 1974-08-03
RO79057A (en) 1982-06-25
NL173645C (en) 1984-02-16
YU17674A (en) 1982-06-18
NL173645B (en) 1983-09-16
RO84276B (en) 1984-07-30
AU6512974A (en) 1975-08-07
YU36956B (en) 1984-08-31
FR2215968A1 (en) 1974-08-30
CS200169B2 (en) 1980-08-29
CA1041502A (en) 1978-10-31
FI58126C (en) 1980-12-10

Similar Documents

Publication Publication Date Title
NO740516L (en) Analogous process for the preparation of pharmacologically active indole derivatives.
NO740272L (en) Analogous process for the preparation of 3-substituted 4-phenylpiperidines.
NO741815L (en) Analogous process for the preparation of therapeutically active ethylene derivatives.
NO741084L (en) Process for the preparation of oral drug preparations.
NO741227L (en) Analogous process for the preparation of therapeutically active penicillin derivatives.
NO149281C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 7ALFA METHOXYPHALOSPORINE DERIVATIVES
SE7416195L (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINS.
NO740327L (en) Analogous process for the preparation of pharmacologically active imidazopyridines.
NO741125A (en) Analogous process for the preparation of therapeutically active pyrido-pyrimidine derivatives.
NO143531C (en) PROCEDURE FOR THE PREPARATION OF ACYLATED BENZOCSAZOLINON DERIVATIVES.
NO741223L (en) Process for the preparation of 6-deoxytetracyclines.
NO741744L (en) Analogous process for the preparation of new therapeutically active derivatives of naphthyridine.
NO740546L (en) Analogous process for the preparation of therapeutically effective tripeptides.
NO740405L (en) Analogous process for the preparation of therapeutically active thienotriazolodiazepine derivatives.
NO741486L (en) Process for the preparation of xylitol.
NO153806C (en) PROCEDURE FOR THE PREPARATION OF 6-DEOXYTE TRACYCLINE.
NO741607L (en) Process for the preparation of isocyanates.
NO741350L (en) Analogous process for the preparation of pharmacologically active benzylamines.
NO740411L (en) Analogous process for the preparation of new therapeutically active derivatives of isoindolin-1-one.
NO740614L (en) Analogous process for the preparation of therapeutically active 2-phenylaminoimidazoline (2) compounds.
FI49504C (en) Process for the preparation of pharmacologically active benzocycloheptaquinoline derivatives.
NO741351L (en) Analogous process for the preparation of physiologically active triazolo-1,5-benzodiazepines.
NO741752L (en) Analogous process for the preparation of therapeutically active amino derivatives of pyrazolopyridine ketones.
FI52735C (en) Process for the preparation of new pregnadiene-21-acid derivatives.
FI52347C (en) Process for the preparation of 21-pregnanoic acid derivatives.